Jeffrey Kindler, the CEO of Pfizer, the world's largest drug-maker, has unexpectedly quit, citing the "incredibly demanding" nature of his job. Although Pfizer suffered mixed fortunes during Kindler's four-plus year tenure and its stock price has slipped by 35 percent, the sudden nature of Kindler's departure has commentators speculating what prompted his exit:
He was exhausted: Running Pfizer "doesn't sound like fun," says Tracy Corrigan at The Daily Telegraph, and "Kindler, to his credit, has been honest enough to say so." Saying his job was "extremely demanding" on a personal level is as close to straight talk as any "statement rewritten by corporate PR advisers can be." I call that a "touchingly human and unpretentious" move.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Do smartphone bans in schools work?The Explainer Trials in UK, New Zealand, France and the US found prohibition may be only part of the solution
-
Doom: The Dark Ages – an 'exhilarating' prequelThe Week Recommends Legendary shooter adds new combat options from timed parries to melee attacks and a 'particularly satisfying' shield charge
-
7 US cities to explore on a microtripThe Week Recommends Not enough vacation days? No problem.
